Related Experiment Video
Updated: Oct 23, 2025

A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19
Published on: July 5, 2022
Bloodstream infections in the COVID-19 era: results from an Italian multi-centre study
Zeno Pasquini1, Iacopo Barocci2, Lucia Brescini2
1Università Politecnica delle Marche Facoltà di Medicina e Chirurgia, Clinica Malattie Infettive, Dipartimento di Scienze Biomediche e Sanità Pubblica, Macerata, Italy; Azienda Ospedaliera Ospedali Riuniti Marche Nord, Malattie Infettive, Pesaro, Italy.
Insights
Bloodstream infections (BSIs) are common in patients with coronavirus disease 2019 (COVID-19), occurring more frequently and with higher mortality. These infections, often caused by resistant bacteria, pose a significant risk during hospitalization.
Area of Science:
- Infectious Diseases
- Epidemiology
- Critical Care Medicine
Background:
- The impact of the COVID-19 pandemic on secondary infections like bloodstream infections (BSIs) requires thorough investigation.
- Previous studies have explored the correlation between COVID-19 and superinfections, but a comprehensive assessment is still needed.
Purpose of the Study:
- To evaluate the incidence and characteristics of bloodstream infections (BSIs) in patients with COVID-19.
- To compare BSI rates and outcomes in COVID-19 patients versus non-COVID-19 patients during the pandemic.
- To analyze the timing of BSI onset and associated mortality in hospitalized patients.
Main Methods:
- A multi-centre study was conducted across four Italian hospitals.
- Data from patients admitted between January 1 and June 30, 2020, were analyzed.
- Clinical, demographic, and microbiological data were compared with data from the same period in 2019 and with non-COVID-19 patients admitted in 2020.
Main Results:
- Patients with COVID-19 had a significantly higher incidence of BSIs (8.19 episodes/1000 patient-days) compared to non-COVID-19 patients (2.72/1000 patient-days) and the 2019 cohort (2.76/1000 patient-days).
- BSI onset was delayed in COVID-19 patients (16 days) versus non-COVID-19 patients (5 days).
- Thirty-day mortality was substantially higher in COVID-19 patients with BSIs (40.2%) compared to those without (23.7%).
- Multi-drug-resistant pathogens frequently caused BSIs in COVID-19 patients, with variations between centers.
Conclusions:
- Bloodstream infections are a significant secondary complication in COVID-19 patients.
- Hospitalized COVID-19 patients face an elevated risk of developing BSIs.
- BSIs in this population are associated with a high mortality rate, underscoring the need for vigilant management.
Background:
Correlation between coronavirus disease 2019 (COVID-19) and superinfections has been investigated, but remains to be fully assessed. This multi-centre study reports the impact of the pandemic on bloodstream infections (BSIs).
Methods:
This study included all patients with BSIs admitted to four Italian hospitals between 1 January and 30 June 2020. Clinical, demographic and microbiologic data were compared with data for patients hospitalized during the same period in 2019.
Results:
Among 26,012 patients admitted between 1 January and 30 June 2020, 1182 had COVID-19. Among the patients with COVID-19, 107 BSIs were observed, with an incidence rate of 8.19 episodes per 1000 patient-days. The incidence of BSI was significantly higher in these patients compared with patients without COVID-19 (2.72/1000 patient-days) and patients admitted in 2019 (2.76/1000 patient-days). In comparison with patients without COVID-19, BSI onset in patients with COVID-19 was delayed during the course of hospitalization (16.0 vs 5 days, respectively). Thirty-day mortality among patients with COVID-19 was 40.2%, which was significantly higher compared with patients without COVID-19 (23.7%). BSIs in patients with COVID-19 were frequently caused by multi-drug-resistant pathogens, which were often centre-dependent.
Conclusions:
BSIs are a common secondary infection in patients with COVID-19, characterized by increased risk during hospitalization and potentially burdened with high mortality.
Related Concept Videos
Bias in Epidemiological Studies
Factors Affecting the Risk of Infection
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...
Sputum Studies II: Culture and Sensitivity
Sputum culture and sensitivity is a medical procedure used to diagnose bacterial infections in the respiratory tract and select the most appropriate antibiotics for treatment. This process involves analyzing sputum samples of thick and opaque secretions produced in the lungs and airways. These samples are collected from patients and then sent to the laboratory for analysis.
The test can identify various pathogens responsible for respiratory infections, including Streptococcus,...
Single Nucleotide Polymorphisms-SNPs
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
Confounding in Epidemiological Studies

